Search - tctmd.com

Displaying 41 - 60 of 89

Sort: Relevancy | Date

Presentation TCT 2016

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

Presenter: Gary M. Ansel, Michael R. Jaff, Herbert D. Aronow

October 30, 2016

Presentation TCT 2016

LIVE-IN-A-BOX CASE DEMONSTRATION: Renal Artery Intervention (Fibromuscular Dysplasia)

Presenter: Gary M. Ansel, Michael R. Jaff, D. Christopher Metzger

October 30, 2016

Presentation TCT 2016

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Presenter: Gary M. Ansel, Michael R. Jaff, Mehdi H. Shishehbor

October 30, 2016

Presentation TCT 2016

Renal Artery Fibromuscular Dysplasia: Natural History and Treatment

Presenter: Gary M. Ansel, Michael R. Jaff

October 30, 2016

Presentation TCT 2016

Atheroscleotic Renal Artery Intervention: What Are the Remaining Indications?

Presenter: Gary M. Ansel, Michael R. Jaff, Sahil A. Parikh

October 30, 2016

Presentation TCT 2016

Catheter-Directed Thrombolysis for Pulmonary Emboli

Presenter: Brian G. DeRubertis, Gary M. Ansel

October 30, 2016

Presentation ISET 2016

Successfully Traversing the Occluded SFA Stent with a Mid-Stent Puncture

Presenter: Gary M. Ansel

February 07, 2016

Presentation ISET 2016

Atherectomy: Some Case Examples of Common Femoral Success

Presenter: Gary M. Ansel

February 07, 2016

Presentation TCT 2015

Clinical Trial Debate: Do DCBs Work for the BTK Indication? No, DCBs Will Never Work in BTK Arteries!

Presenter: Gary M. Ansel, J. A. Mustapha, Ron Waksman

October 12, 2015

Presentation TCT 2015

Clinical Trial Debate: Do DCBs Work for the BTK Indication? Yes, Perform DCB Angioplasty of BTK Lesions Correctly and They Work!

Presenter: Gary M. Ansel, J. A. Mustapha, Francesco Liistro

October 12, 2015

Presentation TCT 2015

After 2 Failed RCTs: Root-Cause Analysis, Unmet Technical Needs and Opportunities for the Development of Next-Generation DCBs, and Studies

Presenter: Gary M. Ansel, J. A. Mustapha

October 12, 2015

Presentation TCT 2015

DCB in BTK Intervention: Summary of the Evidence From 2 Failed RCTs IN.PACT DEEP and BIOLUX P-II

Presenter: Gary M. Ansel, J. A. Mustapha

October 12, 2015

Presentation TCT 2015

BTK Disease: Impact of Disease Complexity on Technical Approach and Clinical Outcomes Are DCBs the Right Answer?

Presenter: Gary M. Ansel, J. A. Mustapha, Peter A. Schneider

October 12, 2015

Presentation TCT 2015

The IN.PACT Global Registry: One-Year Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

Presenter: John R. Laird Jr, Gunnar Tepe, Gary M. Ansel

October 12, 2015

Presentation TCT 2015

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

Presenter: J. A. Mustapha, Craig M. Walker, Gary M. Ansel

October 11, 2015

Presentation TCT 2015

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Presenter: Gary M. Ansel, Michael R. Jaff

October 11, 2015

Presentation TCT 2015

Review and Perspectives of the Global Registry Data for Antiproliferative Therapies

Presenter: Gary M. Ansel, Michael R. Jaff, John R. Laird Jr

October 11, 2015

Presentation TCT 2015

Review of Multicenter, Randomized Outcomes Data of Antiproliferative Therapies: Zilver PTX, LEVANT II, In.PACT SFA, and DEFINITIVE AR

Presenter: Gary M. Ansel, Michael R. Jaff, Ravish Sachar

October 11, 2015

Presentation TCT 2015

Peering Through the Veil: Outcomes Reporting in SFA Intervention Decoded

Presenter: Gary M. Ansel, Michael R. Jaff, William A. Gray

October 11, 2015

Presentation TCT 2015

Everything You Wanted to Know About Endovascular Radiation Hazards but Were Afraid to Ask

Presenter: Gary M. Ansel, Michael R. Jaff, Lindsay S. Machan

October 11, 2015

Advertisement

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

LIVE-IN-A-BOX CASE DEMONSTRATION: Renal Artery Intervention (Fibromuscular Dysplasia)

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Renal Artery Fibromuscular Dysplasia: Natural History and Treatment

Atheroscleotic Renal Artery Intervention: What Are the Remaining Indications?

Catheter-Directed Thrombolysis for Pulmonary Emboli

Successfully Traversing the Occluded SFA Stent with a Mid-Stent Puncture

Atherectomy: Some Case Examples of Common Femoral Success

Clinical Trial Debate: Do DCBs Work for the BTK Indication? No, DCBs Will Never Work in BTK Arteries!

Clinical Trial Debate: Do DCBs Work for the BTK Indication? Yes, Perform DCB Angioplasty of BTK Lesions Correctly and They Work!

After 2 Failed RCTs: Root-Cause Analysis, Unmet Technical Needs and Opportunities for the Development of Next-Generation DCBs, and Studies

DCB in BTK Intervention: Summary of the Evidence From 2 Failed RCTs IN.PACT DEEP and BIOLUX P-II

BTK Disease: Impact of Disease Complexity on Technical Approach and Clinical Outcomes Are DCBs the Right Answer?

The IN.PACT Global Registry: One-Year Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Review and Perspectives of the Global Registry Data for Antiproliferative Therapies

Review of Multicenter, Randomized Outcomes Data of Antiproliferative Therapies: Zilver PTX, LEVANT II, In.PACT SFA, and DEFINITIVE AR

Peering Through the Veil: Outcomes Reporting in SFA Intervention Decoded

Everything You Wanted to Know About Endovascular Radiation Hazards but Were Afraid to Ask

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content